National Institutes of Health Gives Vanderbilt University $1.4 Million for HIV Vaccine Research
February 19, 2014
This article was reported by Ledger-Enquirer.
The Ledger-Enquirer reported that Tennessee's Vanderbilt University received a $1.4 million grant from the US National Institutes of Health to continue its research in HIV treatment and development of an HIV vaccine. While advances in HIV medications have allowed people with HIV to live longer, healthier lives, Vanderbilt doctors say better treatments will curb health threats they face, including increased risk of stroke, heart attack, and other fatal diseases. A vaccine to prevent anyone from becoming infected with HIV is "imperative" said the doctors. Researchers still are trying to figure out why only 30 percent of people in a recent vaccine trial in Thailand seemed to be protected from HIV, while others were not.
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)